ReviewWorld journal of gastroenterology2013
Alcoholism and liver disease in Mexico: genetic and environmental factors.
Review in World journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 63 citations in OpenAlex.
- From NAFLD to MASLD and MetALD: Conceptual Shifts in Metabolic Liver Disease and Their Implications for Mexico.Medicina (Kaunas, Lithuania) · 2026Review
- Mezcal: A Review of Chemistry, Processing, and Potential Health Benefits.Foods (Basel, Switzerland) · 2025Review
- Binge drinking associated with mean temperature: a cross-sectional study among Mexican adults living in cities.Globalization and health · 2024Article
- Examining the effects of parental migration on youth mental health and substance use: a qualitative study in rural Yucatán, México.Frontiers in psychiatry · 2024Article
- Personalized medicine and nutrition in hepatology for preventing chronic liver disease in Mexico.Frontiers in nutrition · 2024Review
- Alcoholic Liver Disease.Clinical liver disease · 2022Review
- Dietary, Cultural, and Pathogens-Related Selective Pressures Shaped Differential Adaptive Evolution among Native Mexican Populations.Molecular biology and evolution · 2022Article
- Liver Diseases in Latin America: Current Status, Unmet Needs, and Opportunities for Improvement.Current treatment options in gastroenterology · 2022Review
- Awareness, Knowledge, and Misperceptions Related to Nonalcoholic Fatty Liver Disease in a Community Sample of Mexican-Origin Women: A Mixed Methods Study.Frontiers in public health · 2021Article
- Interactions betweenNutrients · 2019Article
- Association of Ambient Air Pollution with Increased Liver Enzymes in Korean Adults.International journal of environmental research and public health · 2019Article
- High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population.PloS one · 2019Article
- Clinical features of alcoholic hepatitis in latinos and caucasians: A single center experience.World journal of gastroenterology · 2017Article
- Early Detection of Liver Damage in Mexican Patients with Chronic Liver Disease.Journal of translational internal medicine · 2017Article
- A pedigree-based proxy measure of genetic predisposition of drinking and alcohol use among female sex workers in China: a cross-sectional study.AIDS care · 2017Article
- Development of an in vitro model to test antifibrotic drugs on primary human liver myofibroblasts.Laboratory investigation; a journal of technical methods and pathology · 2016Article
- Article
- Article
- Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico.World journal of gastroenterology · 2015Review
- Genomic medicine in gastroenterology: A new approach or a new specialty?World journal of gastroenterology · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alcoholism and cirrhosis, which are two of the most serious health problems worldwide, have a broad spectrum of clinical outcomes. Both diseases are influenced by genetic susceptibility and cultural traits that differ globally but are specific for each population. In contrast to other regions around the world, Mexicans present the highest drinking score and a high mortality rate for alcoholic liver disease with an intermediate category level of per capita alcohol consumption. Mexico has a unique history of alcohol consumption that is linked to profound anthropological and social aspects. The Mexican population has an admixture genome inherited from different races, Caucasian, Amerindian and African, with a heterogeneous distribution within the country. Thus, genes related to alcohol addiction, such as dopamine receptor D2 in the brain, or liver alcohol-metabolizing enzymes, such as alcohol dehydrogenase class I polypeptide B, cytochrome P450 2E1 and aldehyde dehydrogenase class 2, may vary from one individual to another. Furthermore, they may be inherited as risk or non-risk haplogroups that confer susceptibility or resistance either to alcohol addiction or abusive alcohol consumption and possibly liver disease. Thus, in this era of genomics, personalized medicine will benefit patients if it is directed according to individual or population-based data. Additional association studies will be required to establish novel strategies for the prevention, care and treatment of liver disease in Mexico and worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.